Login to Your Account

Other News To Note

Thursday, March 28, 2013
• MaxCyte Inc., of Gaithersburg, Md., said results published in International Immunopharmacology demonstrated that the use of its cell-loading technology results in fivefold to 20-fold enhancement in potency of dendritic cell vaccines.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription